|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEETS AND STATEMENTS OF OPERATIONS OF BIOLABS, INC. FOR THE QUARTER ENDED JUNE
30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 2,489,051
<SECURITIES> 0
<RECEIVABLES> 18,436
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 2,539,532
<PP&E> 24,992
<DEPRECIATION> (8,953)
<TOTAL-ASSETS> 8,211,968
<CURRENT-LIABILITIES> 1,592,928
<BONDS> 0
0
168
<COMMON> 10,386,386
<OTHER-SE> (3,767,514)
<TOTAL-LIABILITY-AND-EQUITY> 8,211,968
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 878,555
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 28,426
<INCOME-PRETAX> (906,981)
<INCOME-TAX> 0
<INCOME-CONTINUING> (906,981)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (906,981)
<EPS-BASIC> (0.11)
<EPS-DILUTED> (0.11)
</TABLE>
|
|